The Digester

Soft electronics create 'cyborg' islets to speed stem cell diabetes therapy

Mar 4th 2026

Researchers wove flexible microelectrode networks into lab-grown islet organoids to eavesdrop on and steer the electrical maturation of individual cells, improving glucose responsiveness in vitro and offering a new tool to refine and monitor stem cell therapies for type 1 diabetes.

  • Teams from Harvard and the University of Pennsylvania embedded soft, stretchable microelectrode meshes into lab-grown pancreatic islet organoids to record single-cell electrical activity long term.
  • The devices revealed distinct electrical maturation stages for insulin producing beta cells and glucagon secreting alpha cells and tracked how they develop coordinated firing.
  • Exposing organoids to rhythmic glucose cycles and brief electrical pulses sharpened their glucose responsiveness in the lab.
  • The platform could accelerate optimization of stem cell differentiation so transplanted islets reach therapeutic function faster and require fewer cells.
  • Embedded electronics could serve as built-in monitors and eventually support closed loop stimulation to boost insulin output when needed.
  • The approach does not solve immune rejection and still faces major engineering, safety, and regulatory hurdles before any clinical application

Sources

spectrum.ieee.org